LMP2A can block STAT3 activation by inhibiting NF-κB, thereby impairing LMP1 expression, which provides a mechanistic basis for the scenario that NPC cells express LMP2A, but very little LMP1 [167]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.